New formats needed 
Clinical trial data released this year in a study of cisgender men, transgender men, transgender women, and nonbinary individuals who have sex with partners assigned male at birth showed that using lenacapavir results in a 96% 
‘In my view, it’s analogous to dispensing a new drug that you haven’t come across before. You understand the relevant information related to the drug from a safety and effectiveness point of view, you communicate with the patient regarding relevant counselling points, and you document relevant information.’
Antimicrobial use decreasing, but resistance still a threat
Antimicrobial use has declined dramatically in Australia during the pandemic, but the figures show there is no room for complacency.
Interpreting clinical trials and the number needed to treat (NNT)
Pharmacists should be prepared to answer questions from prescribers and health consumers about the effectiveness or appropriateness of medications using evidence-based practices.
Why Linda Badewitz-Dodd MPS won’t accept ‘no’
In this episode of Pharmacy & Me, PSA’s Pharmacist of the Year discusses her incredible career, giving ‘more hugs than drugs’ in times of crisis, her best advice for ECPs and why life is too short to wait for the big moments.
The role of pharmacists in new euthanasia laws
On 29 November 2017, the Victorian Parliament passed the Voluntary Assisted Dying Act 2017.
This is the first time an Australian state government has legislated...
New president lays out her priorities at PSA22
Recently appointed PSA National President Dr Fei Sim used her opening address at PSA22 to lay out her priorities for pharmacy.
Meet the 2023 NSW PSA Excellence Awards winners
They paved the way for expanded scope of practice for pharmacists, vital programs that advanced the profession, important research and opioid harm minimisation.
Four high...
